Amylyx Pharmaceuticals Inc’s recently made public that its Chief Financial Officer FRATES JAMES M unloaded Company’s shares for reported $37806.0 on Mar 31 ’25. In the deal valued at $3.47 per share,10,896 shares were sold. As a result of this transaction, FRATES JAMES M now holds 290,988 shares worth roughly $2.38 million.
Then, Bedrosian Camille L sold 12,425 shares, generating $43,082 in total proceeds. Upon selling the shares at $3.47, the Chief Medical Officer now owns 194,375 shares.
Before that, Mazzariello Gina sold 9,192 shares. Amylyx Pharmaceuticals Inc shares valued at $31,954 were divested by the Chief Legal Officer at a price of $3.48 per share. As a result of the transaction, Mazzariello Gina now holds 187,969 shares, worth roughly $1.54 million.
A number of analysts have revised their coverage, including Guggenheim’s analysts, who began to cover the stock in late June with a ‘”a Buy”‘ rating. Citigroup began covering AMLX with “Buy” recommendation on June 17, 2025. TD Cowen started covering the stock on May 30, 2025. It rated AMLX as “a Buy”.
Price Performance Review of AMLX
On Tuesday, Amylyx Pharmaceuticals Inc [NASDAQ:AMLX] saw its stock jump 2.76% to $8.18. Over the last five days, the stock has gained 2.89%. Amylyx Pharmaceuticals Inc shares have risen nearly 295.17% since the year began. Nevertheless, the stocks have risen 116.40% over the past one year.
How much short interest is there in Amylyx Pharmaceuticals Inc?
A steep rise in short interest was recorded in Amylyx Pharmaceuticals Inc stocks on 2025-07-15, growing by 3.43 million shares to a total of 7.47 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 4.04 million shares. There was a rise of 45.89%, which implies that there is a positive sentiment for the stock.
